13D Filing: Glaxosmithkline Plc and Innoviva Inc. (NASDAQ:INVA)

Page 6 of 6

Page 6 of 6 – SEC Filing

Corporate Executive Team
Emma Walmsley
980 Great West Road
Brentford
Middlesex, England
TW8 9GS
Executive Director and Chief Executive Officer
British
Roger Connor
980 Great West Road
Brentford
Middlesex, England
TW8 9GS
President, Global Manufacturing & Supply
Irish
Simon Dingemans
980 Great West Road
Brentford
Middlesex, England
TW8 9GS
Executive Director and Chief Financial Officer
British
Nick Hirons
980 Great West Road
Brentford
Middlesex
TW8 9GS
Senior Vice President, Global Ethics and Compliance
British & US
Abbas Hussain
980 Great West Road
Brentford
Middlesex, England
TW8 9GS
President, Global Pharmaceuticals
British
David Redfern
980 Great West Road
Brentford
Middlesex, England
TW8 9GS
Chief Strategy Officer
British
Luc Debruyne
980 Great West Road
Brentford
Middlesex, England
TW8 9GS
President, Global Vaccines
Belgian
Claire Thomas
980 Great West Road
Brentford
Middlesex, England
TW8 9GS
Senior Vice President,
Human Resources
British
Philip Thomson
980 Great West Road
Brentford
Middlesex, England
TW8 9GS
President, Global Affairs
British
Daniel Troy
The Navy Yard
5 Crescent Drive
Philadelphia, PA
19112
Senior Vice President & General Counsel
US
 Dr. Patrick Vallance
980 Great West Road
Brentford
Middlesex, England
TW8 9GS
Executive Director & President, R&D
British
Brian McNamara
980 Great West Road
Brentford
Middlesex, England
TW8 9GS
Chief Executive Officer, GSK Consumer Healthcare
US

Follow Innoviva Inc. (NASDAQ:INVA)

Page 6 of 6